Table 3 Univariable and multivariable Cox proportional hazards models to determine predictors of OS.

From: Overall survival is improved when DCIS accompanies invasive breast cancer

Variable

Univariable Analysis

Multivariable Analysis

HR

95% CI

p value

aHR

95% CI

p value

Histology (Ref: IDC alone):

IDC + DCIS

0.74

0.73–0.75

<0.001

0.91

0.89–0.92

<0.001

Age (Ref: <60):

≥60

2.29

2.25–2.33

<0.001

2.14

2.10–2.18

<0.001

Race (Ref: White):

Non-White

1.07

1.05–1.09

<0.001

0.97

0.95–0.98

<0.001

Charlson-Deyo Score (Ref: 0):

≥1

2.15

2.11–2.19

<0.001

1.71

1.68–1.74

<0.001

T Stage (Ref: T1):

T2

2.00

1.96–2.03

<0.001

1.86

1.83–1.90

<0.001

T3

3.10

3.01–3.20

<0.001

2.93

2.83–3.03

<0.001

T4

5.17

5.00–5.34

<0.001

3.92

3.77–4.07

<0.001

N Stage (Ref: N0):

N1

1.84

1.81–1.88

<0.001

1.67

1.63–1.71

<0.001

N2

2.82

2.73–2.92

<0.001

2.29

2.20–2.37

<0.001

N3

4.06

3.87–4.25

<0.001

3.10

2.95–3.26

<0.001

ER Status (Ref: Positive):

Negative

1.89

1.86–1.92

<0.001

1.11

1.07–1.14

<0.001

PR Status(Ref: Positive):

Negative

1.82

1.79–1.85

<0.001

1.26

1.22–1.29

<0.001

Her2 Status (Ref: Negative):

Positive

0.96

0.92–1.00

0.053

0.82

0.79–0.85

<0.001

Unknown

1.09

1.07–1.10

<0.001

1.00

0.98- 1.02

0.846

Surgery Type (Ref: Partial Mastectomy):

Mastectomy

1.75

1.73–1.78

<0.001

0.92

0.90–0.94

<0.001

Radiation Therapy (Ref: No):

Yes

0.52

0.51–0.53

<0.001

0.57

0.56–0.59

<0.001

Chemotherapy (Ref: No):

Yes

0.84

0.83–0.86

<0.001

0.53

0.52–0.54

<0.001

Hormone Therapy (Ref: No):

Yes

0.51

0.50–0.52

<0.001

0.73

0.71–0.75

<0.001

Tumor Grade (Ref: Intermediate):

Low

0.75

0.73–0.77

<0.001

0.81

0.79–0.84

<0.001

High

1.64

1.61–1.67

<0.001

1.36

1.34–1.39

<0.001

  1. Abbreviations: aHR, adjusted hazard ratio; ALND, axillary lymph node dissection; CI, confidence interval; HR, hazard ratio; IDC, invasive ductal carcinoma; IDC + DCIS, invasive ductal carcinoma with ductal carcinoma in situ; OS, overall survival.